MAPT antibody (pSer409)
Quick Overview for MAPT antibody (pSer409) (ABIN2964742)
Target
See all MAPT AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer409
-
Specificity
- Reactivity: Human tau. Species sequence homology: Mouse and rat 100 % .
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic phosphopeptide derived from a region of human tau that contains serine 409. The sequence is conserved in mouse and rat.
Type of Immunogen: Synthetic phospho-peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA, WB (1:1000)
Usage: Suitable for use in ELISA and Western blot. Western Blot: 1:1000. Positive control: Recombinant human Tau left untreated, or treated with PKA. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS (without Mg2+, Ca2+), 1 mg/mL BSA (IgG, protease free), pH 7.3, 0.05 % sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Alternative Name
- MAPT / tau
-
Background
-
Name/Gene ID: MAPT
Synonyms: MAPT, FTDP-17, MSTD, Neurofibrillary tangle protein, PHF-tau, MTBT2, PPND, DDPAC, MAPTL, MTBT1, Paired helical filament-tau, TAU -
Gene ID
- 4137
-
Pathways
- MAPK Signaling, Microtubule Dynamics, M Phase, Regulation of Cell Size
Target
-